Detalhe da pesquisa
1.
Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.
Clin Immunol
; 187: 95-101, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29079163
2.
Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
J Neuroinflammation
; 13(1): 239, 2016 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27599848
3.
Copy number variations in multiple sclerosis and neuromyelitis optica.
Ann Neurol
; 78(5): 762-74, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26296936
4.
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Mult Scler
; 22(10): 1337-48, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26564994
5.
Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
Mult Scler
; 21(9): 1112-20, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25583844
6.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Clin Immunol
; 151(2): 127-35, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24607506
7.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Nat Med
; 13(2): 211-7, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17237795
8.
[Vitamin D and latitude as environmental factors in multiple sclerosis].
Nihon Rinsho
; 72(11): 1924-9, 2014 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-25518372
9.
[Home hospice care, working support and rehabilitation for MS/NMO].
Nihon Rinsho
; 72(11): 2045-50, 2014 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-25518391
10.
Decreased interferon-α production in response to CpG DNA dysregulates cytokine responses in patients with multiple sclerosis.
Clin Immunol
; 143(2): 145-51, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22386492
11.
Neutralizing antibodies are associated with a reduction of interferon-ß efficacy during the treatment of Japanese multiple sclerosis patients.
Tohoku J Exp Med
; 228(2): 85-92, 2012 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22976494
12.
Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.
J Neuroimmunol
; 357: 577624, 2021 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34098399
13.
FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients.
J Neurol
; 271(6): 3643-3647, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38472396
14.
Therapeutic potential of vitamin D for multiple sclerosis.
Curr Med Chem
; 15(5): 499-505, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18289005
15.
Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.
Intern Med
; 57(18): 2647-2655, 2018 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29709955
16.
Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
PLoS One
; 13(3): e0193986, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29518148
17.
Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features.
J Neurol
; 254(4): 488-92, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17401520
18.
Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.
Clin Exp Neuroimmunol
; 8(2): 129-137, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28706565
19.
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.
Mult Scler J Exp Transl Clin
; 3(4): 2055217317748972, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29339837
20.
T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
J Neuroimmunol
; 174(1-2): 108-18, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16564577